Inhibikase Therapeutics (NASDAQ:IKT) reported its Q3 earnings results on Tuesday, November 14, 2023 at 04:20 PM.

Here's what investors need to know about the announcement.

Earnings

Inhibikase Therapeutics beat estimated earnings by 27.73%, reporting an EPS of $-0.86 versus an estimate of $-1.19.

Revenue was up $72 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.19 which was followed by a 6.02% drop in the share price the next day.

To track all earnings releases for Inhibikase Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.